David A. Lehman
Net Worth
Last updated:
What is David A. Lehman net worth?
The estimated net worth of Mr. David A. Lehman is at least $1,260,294 as of 2 Dec 2024. He owns shares worth $302,712 as insider, has earned $369,262 from insider trading and has received compensation worth at least $588,320 in Pulmonx Corporation.
What is the salary of David A. Lehman?
Mr. David A. Lehman salary is $147,080 per year as Gen. Counsel & Sec. in Pulmonx Corporation.
How old is David A. Lehman?
Mr. David A. Lehman is 64 years old, born in 1961.
What stocks does David A. Lehman currently own?
As insider, Mr. David A. Lehman owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | Gen. Counsel & Sec. | 197,851 | $1.53 | $302,712 |
What does Pulmonx Corporation do?
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
David A. Lehman insider trading
Pulmonx Corporation
Mr. David A. Lehman has made 35 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,755 units of LUNG stock worth $17,053 on 2 Dec 2024.
The largest trade he's ever made was exercising 3,083 units of LUNG stock on 1 Mar 2024. As of 2 Dec 2024 he still owns at least 197,851 units of LUNG stock.
Pulmonx key executives
Pulmonx Corporation executives and other stock owners filed with the SEC:
- Mr. David A. Lehman (64) Gen. Counsel & Sec.
- Mr. Geoffrey Beran Rose (52) Chief Commercial Officer
- Mr. Glendon E. French (63) Chief Executive Officer, Pres & Director